Last reviewed · How we verify
Adapalene 0.1% and Benzoyl Peroxide 2.5% gel — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Adapalene 0.1% and Benzoyl Peroxide 2.5% gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% gel) — Galderma R&D.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Adapalene 0.1% and Benzoyl Peroxide 2.5% gel TARGET | Adapalene 0.1% and Benzoyl Peroxide 2.5% gel | Galderma R&D | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Adapalene 0.1% and Benzoyl Peroxide 2.5% gel CI watch — RSS
- Adapalene 0.1% and Benzoyl Peroxide 2.5% gel CI watch — Atom
- Adapalene 0.1% and Benzoyl Peroxide 2.5% gel CI watch — JSON
- Adapalene 0.1% and Benzoyl Peroxide 2.5% gel alone — RSS
Cite this brief
Drug Landscape (2026). Adapalene 0.1% and Benzoyl Peroxide 2.5% gel — Competitive Intelligence Brief. https://druglandscape.com/ci/adapalene-0-1-and-benzoyl-peroxide-2-5-gel. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab